These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11702018)

  • 1. Differences in substantia nigra echogenicity of nosological subtypes within the schizophrenic spectrum. A preliminary transcranial ultrasound study.
    Jabs BE; Berg D; Merschdorf U; Bartsch AJ; Pfuhlmann B
    Neuropsychobiology; 2001; 44(4):183-6. PubMed ID: 11702018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility to neuroleptic-induced parkinsonism--age and increased substantia nigra echogenicity as putative risk factors.
    Jabs BE; Bartsch AJ; Pfuhlmann B
    Eur Psychiatry; 2003 Jun; 18(4):177-81. PubMed ID: 12814851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial sonographic findings may predict prognosis of gastroprokinetic drug-induced parkinsonism.
    Oh YS; Kwon DY; Kim JS; Park MH; Berg D
    Parkinsonism Relat Disord; 2018 Jan; 46():36-40. PubMed ID: 29111425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy.
    Berg D; Jabs B; Merschdorf U; Beckmann H; Becker G
    Biol Psychiatry; 2001 Sep; 50(6):463-7. PubMed ID: 11566164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking and neuroleptic-induced parkinsonism.
    Decina P; Caracci G; Sandik R; Berman W; Mukherjee S; Scapicchio P
    Biol Psychiatry; 1990 Sep; 28(6):502-8. PubMed ID: 1977478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
    Li DH; Zhang LY; Hu YY; Jiang XF; Zhou HY; Yang Q; Kang WY; Liu J; Chen SD
    Parkinsonism Relat Disord; 2015 Aug; 21(8):923-8. PubMed ID: 26066091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound.
    Berg D; Becker G; Zeiler B; Tucha O; Hofmann E; Preier M; Benz P; Jost W; Reiners K; Lange KW
    Neurology; 1999 Sep; 53(5):1026-31. PubMed ID: 10496262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra echogenicity is correlated with nigrostriatal impairment in Machado-Joseph disease.
    Pedroso JL; Bor-Seng-Shu E; Felício AC; Braga-Neto P; Hoexter MQ; Teixeira MJ; Bressan RA; Barsottini OG
    Parkinsonism Relat Disord; 2013 Aug; 19(8):742-5. PubMed ID: 23680416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigens in drug-induced parkinsonism.
    Metzer WS; Newton JE; Steele RW; Claybrook M; Paige SR; McMillan DE; Hays S
    Mov Disord; 1989; 4(2):121-8. PubMed ID: 2567491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substantia nigra hyperechogenicity as a marker of predisposition and slower progression in Parkinson's disease.
    Schweitzer KJ; Hilker R; Walter U; Burghaus L; Berg D
    Mov Disord; 2006 Jan; 21(1):94-8. PubMed ID: 16114024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to measure substantia nigra hyperechogenicity in Parkinson disease: detailed guide with video.
    Walter U
    J Ultrasound Med; 2013 Oct; 32(10):1837-43. PubMed ID: 24065265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease.
    Weise D; Lorenz R; Schliesser M; Schirbel A; Reiners K; Classen J
    Mov Disord; 2009 Aug; 24(11):1669-75. PubMed ID: 19514075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinsonism due to ephedrone neurotoxicity: a case report.
    Colosimo C; Guidi M
    Eur J Neurol; 2009 Jun; 16(6):e114-5. PubMed ID: 19453409
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperechogenicity of the substantia nigra in Parkinson's disease.
    Ressner P; Skoloudík D; Hlustík P; Kanovský P
    J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
    Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
    Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of drug-induced parkinsonism: can transcranial sonography make the difference?
    Poewe W; Seppi K
    Eur J Neurol; 2013 Nov; 20(11):1429-30. PubMed ID: 23678988
    [No Abstract]   [Full Text] [Related]  

  • 17. No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease.
    Lobsien E; Schreiner S; Plotkin M; Kupsch A; Schreiber SJ; Doepp F
    Mov Disord; 2012 Mar; 27(3):450-3. PubMed ID: 22237792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of restless legs syndrome is inversely correlated with echogenicity of the substantia nigra in different neurodegenerative movement disorders. a preliminary observation.
    Pedroso JL; Bor-Seng-Shu E; Felicio AC; Braga-Neto P; Dutra LA; de Aquino CC; Ferraz HB; do Prado GF; Teixeira MJ; Barsottini OG
    J Neurol Sci; 2012 Aug; 319(1-2):59-62. PubMed ID: 22632781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonography for diagnosis of Parkinson disease-from theory to practice: a study on 300 participants.
    Alonso-Cánovas A; López-Sendón JL; Buisán J; deFelipe-Mimbrera A; Guillán M; García-Barragán N; Corral I; Matute-Lozano MC; Masjuan J; Martínez-Castrillo JC; Walter U
    J Ultrasound Med; 2014 Dec; 33(12):2069-74. PubMed ID: 25425362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.